Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03865303 · ClinicalTrials.gov registry record
Learning Lab for Diagnostic Fidelity
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 25,551
- Enrollment target
NCT03865303: Completed study, sponsored by Mayo Clinic.
NCT03865303 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 25,551 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03865303 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 25,551 participants
- Enrollment target
Study Summary
Diagnostic error and delay remain a leading cause of preventable harm and death in the United States. Using a learning laboratory structure, researchers will implement mixed-methods research approaches to identify the systemic weaknesses that contribute to diagnostic error and delay in the hospital setting. The knowledge gained from research innovative will allow researchers to design, develop, implement, and refined a suite of human-centered tools that can be deployed to reduce the risk of diagnostic error and delay in both community and academic hospital settings.
Primary Outcome
Use data from the patient electronic medical record to identify the number of diagnostic error or delay to validate clinical environment automated phenotypes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25,551 participants |
| Start Date | 2019-04-22 |
| Est. Completion | 2022-11-30 |
What the finished NCT03865303 record still lists
NCT03865303 is an observational study that tracks outcomes without assigning an intervention. Its 25,551 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03865303 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03865303 about?
NCT03865303 is a clinical study titled "Learning Lab for Diagnostic Fidelity". Diagnostic error and delay remain a leading cause of preventable harm and death in the United States. Using a learning laboratory structure, researchers will implement mixed-methods research approaches to identify the systemic weaknesses that contribute to diagnostic error and delay in the hospital ...
What is the current status of trial NCT03865303?
This trial is currently completed. The enrollment target is 25,551 participants. The study started on 2019-04-22. Estimated completion is 2022-11-30.
Who is sponsoring clinical trial NCT03865303?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07300839 · 25,500 participants · Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
- NCT03175302 · 25,240 participants
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
- NCT04595201 · 25,000 participants
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
- NCT04994015 · 25,000 participants
Parkinson's Foundation PD GENEration Genetic Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI